The Association Between Antidepressant Treatment and Heart Rate Deceleration Capacity in Patients With Mood

Hiroaki Okayasu1, Norio Sugawara1, Kumiko Fujii2

  • 1Department of Psychiatry, Dokkyo Medical University, Shimotsuga, Tochigi, Japan.

Insights

Antidepressant use in mood disorder patients correlates with decreased heart rate deceleration capacity (DC), a predictor of cardiac death. This study found lower DC in patients on antidepressants, suggesting DC evaluation may improve sudden cardiac death risk prediction.

Area of Science:

  • Cardiology
  • Psychiatry
  • Pharmacology

Background:

  • Patients with mood disorders using antidepressants face elevated risks of sudden cardiac death.
  • QT interval prolongation is a known risk factor, but its association with antidepressants lacks clarity.
  • Decreased heart rate deceleration capacity (DC) is emerging as a significant predictor of cardiac mortality.

Purpose of the Study:

  • To reevaluate the risk of sudden cardiac death in patients with mood disorders undergoing antidepressant treatment.
  • To assess the association between antidepressant use and heart rate deceleration capacity (DC).

Main Methods:

  • Investigated the correlation between DC and antidepressant/psychotropic drug doses in 107 patients with major depressive disorder (MDD) or bipolar disorder (BD) using linear regression.
  • Compared DC in MDD patients taking antidepressants with age- and sex-matched healthy controls.

Main Results:

  • DC showed a negative, dose-dependent correlation with both tricyclic antidepressants (TCAs) and non-tricyclic antidepressants (non-TCAs).
  • MDD patients on antidepressants exhibited significantly lower DC (5.32 ms) compared to healthy controls (7.60 ms).

Conclusions:

  • Tricyclic antidepressant use significantly impacts DC decline; non-TCAs may also influence DC, especially with polypharmacy.
  • Evaluating DC can enhance the predictive accuracy for sudden cardiac death in mood disorder patients using antidepressants.
Abstract

Related Concept Videos

Decreased pulse rate01:14

Decreased pulse rate

Bradycardia is a medical condition in which the heart rate is slower than normal. It occurs when the heart's natural pacemaker, the sinus node, generates slower electrical impulses than the standard rhythm. In adults, bradycardia is diagnosed when the pulse rate falls below 60 beats per minute, indicating a deviation from the normal heart rate range.
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
522
Factors Influencing Heart Rate01:30

Factors Influencing Heart Rate

The heart rate, or pulse rate, is a vital indicator of cardiovascular health. It reflects the number of times the heart beats per minute. Various physiological and environmental factors influence heart rate, increasing or decreasing cardiac output. Understanding these factors is crucial for assessing heart function and identifying potential health issues.
Let us explore the significant factors affecting heart rate, including age, body temperature, posture, acute pain, chemical influences,...
2.2K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
173
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
354
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
691
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
772